Observational studySurgical endoscopy2025
Should we let the sun set or rise on a small bowel obstruction: mortality and readmission rates in operative versus nonoperative management.
Observational study in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a CT-based body composition model for predicting adverse outcomes in small bowel obstruction.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecurrent small bowel obstruction (SBO) can result in significant morbidity and mortality. In this study, we aimed to compare readmission and its impact on operatively and nonoperatively managed patients admitted with SBO.
methodsWe performed a retrospective analysis using the National Readmission Database 2016-2017 and included all patients (≥ 18y) who were non-elective admissions for SBO during the index hospitalization. Patients were dichotomized into two groups: Operative group (OM) and nonoperative group (NOM). Primary outcomes included rates of readmission and mortality upon readmission. Secondary outcomes included complications, which were defined as fistula, abscess, perforation, peritonitis, and sepsis.
results122,778 patients admitted for SBO were included. Overall, the readmission was 29.8%, with 34.4% readmitted within 30 days. 6.4% were OM, while 93.6% were NOM during index admission. Among OM patients, the readmission rate was significantly lower at 28.6% compared to NOM at 29.9% (p < 0.001). Among the readmitted NOM patients, 88.3% had emergency readmissions, with 10.6% requiring operative intervention. Adjusted analyses revealed that NOM had 32% higher odds of readmission (p < 0.001). Other factors increasing the odds of readmission included female sex, a high Charlson comorbidity index, and an admission diagnosis of cancer. Among readmitted patients, NOM had 50% higher odds of mortality during readmission. Each readmission raised the odds of mortality by 4.0% (p < 0.001). Operative management in the first readmission was associated with younger age, private insurance status, and non-operative management during the index admission.
conclusionWhile cost, length of stay, and complications were higher in OM, NOM was associated with a higher readmission rate and mortality upon readmission. Each additional readmission for small bowel obstruction increased the odds of mortality by 4.0%.
Indexed as
Identifiers
40938369What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.